NEUTRISCI ANNOUNCES EXCLUSIVE DISTRIBUTION DEAL
VANCOUVER, British Columbia, May 02, 2019 (GLOBE NEWSWIRE) – NeutriSci International Inc. (“NeutriSci”) (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) the innovator and pioneer behind neuenergy® is pleased to announce effective May 1st, 2019 ANB Canada Inc. (“ANB”) will assume all responsibilities for retail sales and distribution of neuenergy® products in Canada.
ANB is one of the leading distributors of over-the-counter (“OTC”) products in Canada, and services all Food, Drug and Mass in the Canadian market place from national to regional accounts.
ANB not only markets, sells, warehouses and distributes consumer OTC brands, but also helps manufacturers in several areas, including generating brand awareness. ANB currently represents the brands of many manufacturers across many different product lines.
“We are very pleased to have ANB assume the responsibility of sales and distribution of neuenergy in Canadian retail market,” stated Glen Rehman, CEO of NeutriSci. “As part of our agreement with ANB, we will continue to handle online sales, and sales through our Ambassador Program. This move will allow us to streamline our internal operations while at the same time achieve expanded retail distribution of neuenergy in the Canadian marketplace. Working with ANB will provide the Company with the opportunity to have neuenergy available for sale in many of the retailers that ANB works with specific retailers such as Shopper’s Drug Mart, Walmart and Costco.”
On Behalf of the Board of Directors of
NEUTRISCI INTERNATIONAL INC.
Tel: (403) 264-6320
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.
About NeutriSci International Inc.
NeutriSci specializes in the innovation, production and formulation of nutraceutical products. Established in 2009, NeutriSci’s is building sustainable sales models with Convenience, Chain Drug, and Mass Market and Supermarket retailers for neuenergy®, the Company’s natural energy and focus supplement that has at its core, the beneficial effects of blueberries.
Neuenergy® contains a unique patented combination of blueberry extract (pterostilbene) and naturally derived caffeine, and is a revolutionary energy tab designed to deliver enhanced focus and mental clarity with no sugar, no calories and no crash associated with typical energy products. To find out more about neuenergy®, please visit www.getneuenergy.com.
For more information, please visit: www.neutrisci.com.
About ANB Canada Inc.
ANB Canada offers turnkey over-the-counter (“OTC”) sales and distribution services to manufacturers in the Canadian Food, Drug and Mass marketplace. ANB Canada not only markets, sells, warehouses and distributes consumer OTC brands, but also helps manufacturers in a number of other areas including navigating Canadian regulatory guidelines. To find out more about ANB Canada, please visit www.anbcanada.com.
Statements in this press release have not been evaluated by the Food and Drug Administration. Products or ingredients are not intended to diagnose, treat, cure or prevent any disease.